Metrika članka

  • citati u SCindeksu: 0
  • citati u CrossRef-u:0
  • citati u Google Scholaru:[=>]
  • posete u poslednjih 30 dana:2
  • preuzimanja u poslednjih 30 dana:1
članak: 6 od 121  
Back povratak na rezultate
Acta medica Medianae
2019, vol. 58, br. 4, str. 80-84
jezik rada: engleski
vrsta rada: pregledni članak
objavljeno: 24/02/2020
doi: 10.5633/amm.2019.0412_NE_RADI
Creative Commons License 4.0
Uloga starih antibiotika u prevazilaženju rezistencije na antibiotike
aUniverzitet u Nišu, Medicinski fakultet, Katedra Farmakologija sa toksikologijom
bUniverzitet u Nišu, Medicinski fakultet + Klinički centar Niš, Klinika za plućne bolesti
cUniverzitet u Nišu, Medicinski fakultet, Katedra Farmakologija sa toksikologijom + Klinički centar Niš, Klinika za onkologiju
dKlinički centar Niš, Klinika za onkologiju + Univerzitet u Nišu, Medicinski fakultet
ePrimary Health Center Niš, Women's Health Service

e-adresa: dane.krtinic@medfak.ni.ac.rs

Projekat

Preventivni, terapijski i etički pristup prekliničkim i kliničkim istraživanjima gena i modulatora redoks ćelijske signalizacije u imunskom, inflamatornom i proliferativnom odgovoru ćelije (MPNTR - 41018)
Internal scientific research projects of the Faculty of Medicine, University of Niš No 34
Internal scientific research projects of the Faculty of Medicine, University of Niš No 37

Sažetak

Antibiotici su lekovi koji se koriste za sprečavanje ili lečenje infekcija uzrokovanih bakterijama. Otkrivanje i uvođenje antibiotika u medicinsku praksu dovelo je do revolucionarnih promena u terapiji i iskorenjivanju infektivnih bolesti. Trenutno postoji povećanje interesa za korišćenje starih antibiotika. Ovi lekovi mogu biti neprocenjivi u lečenju određenih infekcija i, kako bi oni ostali efikasni, neophodno je sprovesti određene mere koje bi mogle dokazati njihovu vrednost. Cilj antibiotske terapije je da se isporuči antibiotik do mesta infekcije i da se zadrži na mestu infekcije u dužem vremenskom periodu. Pre svega, izuzetno je važno edukovati, na ovu temu, sve zdravstveno osoblje u sistemu zdravstvene zaštite, posebno lekare. Činjenica da je dostupnost ovih lekova i dalje niska, u odnosu na napore u pokušaju otkrivanja novih antibiotika, nameće potrebu da se nacionalne regulatorne agencije uključe u regulisanje korištenja ovih lekova.

Ključne reči

Reference

*** (2016) United Nations meeting on antimicrobial resistance. Bulletin of the World Health Organization, 94(9): 638-639
Allington, D.R., Rivey, M.P. (2001) Quinupristin/dalfopristin: A therapeutic review. Clinical Therapeutics, 23(1): 24-44
Andrews, J.M., Jevons, G., Walker, R., Ashby, J., Fraise, A.P. (2007) Temocillin susceptibility by BSAC methodology. Journal of Antimicrobial Chemotherapy, 60(1): 185-187
Bergen, P.J., Landersdorfer, C.B., Lee, H.J., Li, J., Nation, R.L. (2012) 'Old' antibiotics for emerging multidrug-resistant bacteria. Current opinion in infectious diseases, 25 (6):626-33
Bialvaei, A.Z., Samadi, K.H. (2015) Colistin, mechanisms and prevalence of resistance. Current Medical Research and Opinion, 31(4): 707-721
Cassir, N., Rolain, J.M., Brouqui, P. (2014) A new strategy to fight antimicrobial resistance: The revival of old antibiotics. Frontiers in Microbiology, 5: 551-551
Deacon, J., Abdelghany, S.M., Quinn, D.J., Schmid, D., Megaw, J., Donnelly, R.F., Jones, D.S., Kissenpfennig, A., Elborn, J., Gilmore, B.F., Taggart, C.C., Scott, C.J. (2015) Antimicrobial efficacy of tobramycin polymeric nanoparticles for Pseudomonas aeruginosa infections in cystic fibrosis: Formulation, characterisation and functionalisation with dornase alfa (DNase). Journal of Controlled Release, 198: 55-61
Falagas, M.E., Grammatikos, A.P., Michalopoulos, A. (2008) Potential of old-generation antibiotics to address current need for new antibiotics. Expert Review of Anti-infective Therapy, 6(5): 593-600
Gootz, T.D. (1990) Discovery and development of new antimicrobial agents. Clinical Microbiology Reviews, 3(1): 13-31
Kalita, S., Devi, B., Kandimalla, R., Sharma, K.K., Sharma, A., Kalita, K. (2015) Chloramphenicol encapsulated in poly-e-caprolactone-pluronic composite: Nanoparticles for treatment of MRSA-infected burn wounds. Int J Nanomedicine, 10: 2971-84
Kristich, C.J., Rice, L.B., Arias, C.A. (2014) Enterococcal infection-treatment and antibiotic resistance. u: Gilmore M.S.; Clewell D.B.; Ike Y.; Shankar N. [ur.] Enterococci: From commensals to leading causes of drug resistant infection, Boston: Massachusetts Eye and Ear Infirmary
McKinnell, J.A., Stollenwerk, N.S., Jung, C.W., Miller, L.G. (2011) Nitrofurantoin compares favorably to recommended agents as empirical treatment of uncomplicated urinary tract infections in a decision and cost analysis. Mayo Clinic Proceedings, 86(6): 480-488
Młynarczyk-Bonikowska, B., Kujawa, M., Młynarczyk, G., Malejczyk, M., Majewski, S. (2015) Susceptibility of neisseria gonorrhoeae strains isolated in Poland in 2012-2013 to spectinomycin. Med Dosw Mikrobiol, 67(1): 23-8
Poole, K. (2004) Resistance to beta-lactam antibiotics. Cellular and Molecular Life Sciences, 61(17): 2200-2223
Prestinaci, F., Pezzotti, P., Pantosti, A. (2015) Antimicrobial resistance: A global multifaceted phenomenon. Pathogens and Global Health, 109(7): 309-318
Rodgers, A., Aminov, R.I. (2010) A brief history of the antibiotic era: Lessons learned and challenges for the future. Front Microbiol, 1: 134-134
Stock, I. (2015) Fosfomycin: Its significance for treatment of diseases due to multidrug-resistant bacteria. Med Monatsschr Pharm, 38(1): 4-11
Ventola, L.C. (2015) The Antibiotic Resistance Crisis, Part 1: Causes and Threats. Pharmacy & Therapeutics, 40(4): 277-83
Wang, T., Li, N., Hu, S., Xie, J., Lei, J., Wang, Y., Zheng, X., Xing, J., Dong, Y. (2015) Factors on trough teicoplanin levels, associations between levels, efficacy and safety in patients with gram-positive infections. Int. Journal of Clinical Pharmacology and Therapeutics, 53(05): 356-362
Yocum, R.R., Rasmussen, J.R., Strominger, J.L. (1980) The mechanism of action of penicillin: Penicillin acylates the active site of bacillus stearothermophilus d-alanine carboxypeptidase. J Biol Chem, 255(9): 3977-86